Peter Radovich - 09 Aug 2023 Form 4 Insider Report for Rain Oncology Inc.

Role
Director
Signature
/s/ Avanish Vellanki, Attorney-in-fact for Peter Radovich
Issuer symbol
N/A
Transactions as of
09 Aug 2023
Net transactions value
$0
Form type
4
Filing time
11 Aug 2023, 21:12:50 UTC
Previous filing
05 Jul 2023
Next filing
15 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +35,000 $0.000000 35,000 09 Aug 2023 Common Stock 35,000 $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 35,000 shares of the Issuer's common stock, which will vest in full on the date of the 2024 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service to the Issuer.